Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MentalPlus® for Assessment and Rehabilitation of Cognitive Functions After Remission of Symptoms of COVID-19

NCT04632719 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT04632719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04632719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MentalPlus® for Assessment and Rehabilitation of Cognitive Functions After Remission of Symptoms of COVID-19
Lead sponsor
University of Sao Paulo
Phase
Not applicable
Overall status
Completed
Start date
November 8, 2020
Completion date
December 29, 2023
Enrollment
200 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive dysfunction, cognitive impairment, covid19, depression, anxiety, quality of life